by Aptamers are single-stranded DNA or RNA molecules that are selected through an in vitro selection process known as SELEX to bind to a specific target molecule. They offer promising advantages over antibodies as therapeutic and diagnostic agents such as high affinity and specificity for targets, low immunogenicity, relatively cheap production costs and easy chemical modification as per requirements. As aptamers can recognize a broad range of target molecules including proteins, peptides, cells and even whole organisms, they are finding wide ranging applications in areas such as healthcare, biodetection, biosensors and others.
The global Aptamers Market is estimated to be valued at US$ 6265.49 Mn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the aptamers market is the increasing research and development activities for developing aptamers for novel therapeutic applications. As aptamers can bind to a wide range of molecular targets including proteins and cells, significant R&D is being focused on developing aptamers for drugs to treat critical diseases such as cancer, cardiovascular diseases and others. Additionally, researchers are developing aptamers for molecular diagnostics applications such as detection of pathogens and biomarkers. This increasing R&D activity is anticipated to boost the growth of the aptamers market over the forecast period.
Porter’s Analysis
Threat of new entrants: Low as the aptamers market requires significant capital, infrastructure and expertise. Bargaining power of buyers: Moderate as large pharma companies can negotiate better prices. Bargaining power of suppliers: Moderate as the raw materials for aptamers are commoditised. Threat of new substitutes: Low as aptamers have unique targeted binding properties versus other modalities. Competitive rivalry: High as larger players invest significantly in R&D to develop innovative aptamer-based products.
Key Takeaways
The Global Aptamers Market Size is expected to witness high growth. The global Aptamers Market is estimated to be valued at US$ 6265.49 Mn in 2023 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023 to 2030.
The Asia Pacific region is expected to grow at the fastest rate owing to rising R&D expenditure and increasing outsourcing of clinical trials to countries like China and India.
Key players operating in the aptamers market are ContiTech Australia Pty. Ltd., Endless Belt Service Pty Ltd., Fenner Dunlop Australia Pty Ltd, Flexible Steel Lacing Company (Flexco), Kinder Australia Pty Ltd., Mato GmbH & Co. KG., Minprovise Pty Ltd, Nepean Engineering & Innovation Pty Ltd., Reliable Conveyor Belt Pty. Ltd., Rema Tip Top Australia, Forbo Siegling PTY. Ltd., and others. They are focusing on expanding their geographical presence and investing in development of innovative aptamer-based products.
